Abstract
Direct injection of naked plasmid DNA either intramuscularly or intradermally induces strong, long-lived immune responses to the antigen encoded by the gene vaccine. While the intradermal route of administration appears to be the most efficient, there is evidence that either route leads to production of antibody and the activation of major histocompatibility complex (MHC) class I-restricted, antigen-specific cytotoxic T lymphocytes (CTL) and MHC class II-restricted CD4+ T cells secreting Thl-type cytokines such as interferon-γ (IFN-γ) [1–9]. Plasmid DNA immunization has potential advantages compared to traditional protein vaccination due to the strong CTL and Thl responses induced, the prolonged antigen expression, and the resistance of the antigen source to antibody-mediated clearance. As a consequence, gene vaccination has potential applications in the fields of infectious diseases, allergy and cancer.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL (1993) DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Nat] Acad Sci USA 90: 11478
Davis HL, Schirmbeck R, Reimann J, Whalen RG (1995) DNA-mediated immunization in mice induces a potent MHC class I-restricted cytotoxic T lymphocyte response to the hepatitis B envelope protein. Hum Gene Ther 6: 1447
Manickan E, Rouse RJ, Yu Z, Wire WS, Rouse BT (1995) Genetic immunization against herpes simplex virus. Protection is mediated by CD4’ T lymphocytes. J Immunol 155: 259
Raz E, Carson DA, Parker SE, et al (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91: 9519
Whalen RG, Leclerc C, Deriaud E, Schirmbeck R, Reimann J, Davis HL (1995) DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response. Ann N Y Acad Sci 772: 64
Xiang Z, Ertl HC (1995) Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2: 129
Ulmer JB, Donnelly JJ, Parker SE, et al (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein [see comments]. Science 259: 1745
Raz E, Tighe H, Sato Y, Corr M, Dudler JA, Roman M, Swain SL, Spiegelberg HL, Carson DA (1996) Preferential induction of a Thl immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 93: 5141
Watanabe A, Raz E, Kohsaka H, Tighe H, Baird SM, Kipps TJ, Carson DA (1993) Induction of antibodies to a kappa V region by gene immunization. J Immunol 151: 2871
Neefjes JJ, Ploegh HL (1992) Intracellular transport of MHC class II molecules. Immunol Today 13: 179
Hohlfeld R, Engel AG (1994) The Immunobiology of muscle. Immunol Today 15: 269
Nickloff BM (1993) Dermal immune system. CRC Press, Boca Raton
Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247: 1465
Austyn JM, Hankins DF, Larsen CP, Morris PJ, Rao AS, Roake JA (1994) Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol 152: 2401
Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nature Med 2: 1122
Pardoll DM, Beckerleg AM (1995) Exposing the immunology of naked DNA vaccines. Immunity 3: 165
Nichols WW, Ledwith BJ, Manam SV, Troilo PJ (1995) Potential DNA vaccine integration into host cell genome. Ann N Y Acad Sci 772: 30
Ulmer JB, Donnelly JJ, Deck RR, DeWitt CM, Liu MA (1995) Immunization against viral proteins with naked DNA. Ann N Y Acad Sci 772: 117
Schwartz RH (1992) Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71: 1065
Schwartz RH (1996) Models of T cell anergy: is there a common molecular mechanism? [comment]. J Exp Med 184: 1
Lamb JR, Skidmore Bi, Green N, Chiller JM, Feldmann M (1983) Induction of tolerance in influenza virus-immune T lymphocyte clones with synthetic peptides of influenza hemagglutinin. J Exp Med 157: 1434
Jenkins MK, Schwartz RH (1987) Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med 165: 302
Quill H, Schwartz RH (1987) Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J Immunol 138: 3704
Mueller DL, Jenkins MK, Schwartz RH (1989) Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7: 445
Kundig TM, Bachmann MF, DiPaolo C, et al (1995) Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science 268: 1343
Kovacsovics-Bankowski M, Rock KL (1994) Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur J Immunol 24: 2421
Kovacsovics-Bankowski M, Rock KL (1995) A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 267: 243
Reis e Sousa C, Germain RN (1995) Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis. J Exp Med 182: 841
Rudolphi A, Spiess S, Conradt P, Claesson MH, Reimann J (1991) CD3* T cells in severe combined immunodeficiency (scid) mice. II. Transplantation of dm2 lymphoid cells into semi-allogeneic seid mice. Eur J Immunol 21: 1591
Claesson MH, Rudolphi A, Tscherning T, Reimann J (1991) CD3* T cells in severe combined immunodeficiency (scid) mice. IV. Graft-vs.-host resistance of H-2d scid mice to intravenous injection of allogeneic H-2b (C57BL/6) spleen cells. Eur J Immunol 21: 2057
Doe B, Selby M, Barnett S, Baenziger J, Walker CM (1996) Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93: 8578
Corr M, Lee DJ, Carson DA, Tighe H (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184: 1555
Monaco JJ, Cho S, Attaya M (1990) Transport protein genes in the murine MHC: possible implications for antigen processing. Science 250: 1723
Townsend A, Trowsdale J (1993) The transporters associated with antigen presentation. Semin Cell Biol 4: 53
Yewdell JW, Bennink JR (1992) Cell biology of antigen processing and presentation to major histocompatibility complex class I molecule-restricted T lymphocytes. Adv Immunol 52: 1
Dick LR, Aldrich C, Jameson SC, Moomaw CR, Pramanik BC, Doyle CK, DeMartino GN, Bevan MJ, Forman JM, Slaughter CA(1994) Proteolytic processing of ovalbumin and beta-galactosidase by the proteasome to a yield antigenic peptides. J Immunol 152: 3884
Schirmbeck R, Melber K, Reimann J (1995) Hepatitis B virus small surface antigen particles are processed in a novel endosomal pathway for major histocompatibility complex class I-restricted epitope presentation. Eur J Immunol 25: 1063
Bohm W, Schirmbeck R, Elbe A, Melber K, Diminky D, Kraal G, Rooijen N van, Barenholz Y, Reimann J (1995) Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted cytotoxic T lymphocytes in vivo. J Immunol 155: 3313
Martinez-Kinader B, Lipford GB, Wagner H, Heeg K (1995) Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway. Immunology 86: 287
Ulmer JB, Deck RR, Dewitt CM, Donnhly JI, Liu MA (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89: 59
Bevan MJ (1976) Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 con-genic cells which do not cross-react in the cytotoxic assay. J Exp Med 143: 1283
Huang AY, Golumbek P, Ahmadzadeh M, Jaffee E, Pardoll D, Levitsky H (1994) Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens. Science 264: 961
Suto R, Srivastava PK (1995) A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269: 1585
Harding CV, Song R (1994) Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J Immunol 153: 4925
Huang AY, Bruce AT, Pardoll DM, Levitsky HI (1996) In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter. Immunity 4: 349
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Corr, M., Tighe, H. (1998). Plasmid DNA vaccination: mechanism of antigen presentation. In: Raz, E. (eds) Gene Vaccination: Theory and Practice. Principles and Practice. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-46867-4_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-46867-4_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-46869-8
Online ISBN: 978-3-642-46867-4
eBook Packages: Springer Book Archive